Guardant Health, Inc. provided earnings guidance for the full year 2022. For the period, the company expects revenue to be in the range of $440 million to $450 million, representing growth of 18% to 20% compared to full year 2021. This compares to previous full year 2022 revenue guidance of $460 million to $470 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
15.88 USD | -4.74% | -12.98% | -41.26% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.26% | 2.03B | |
-18.25% | 11.52B | |
+35.49% | 3.27B | |
-20.67% | 2.02B | |
-30.46% | 1.44B | |
+9.92% | 1.01B | |
-6.33% | 719M | |
-32.83% | 418M | |
-51.12% | 339M | |
-2.58% | 284M |
- Stock Market
- Equities
- GH Stock
- News Guardant Health, Inc.
- Guardant Health, Inc. Provides Earnings Guidance for the Full Year 2022